StockData
Alvotech logo

Alvotech (ALVO) stock

ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.37−0.04 (-0.79%)

Close on Nov 17, 2026Market cap $1.36BP/E 43.7Yield –

Alvotech ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was $116.06M, up 15.0% from the year before. The highest annual figure on record is $116.06M in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$116.06M+15.0%
FY2024Dec 31, 2024$100.95M–
FY2023Dec 31, 2023-$330.65M–
FY2022Dec 31, 2022-$326.03M–
FY2021Dec 31, 2021-$217.26M–
FY2020Dec 31, 2020-$121.12M–

More Alvotech figures

See a number that looks wrong?